Maximum Treatment Interval With Aflibercept T&E

Clinical trial NCT05342857 · UNKNOWN

Trial details

NCT number: NCT05342857
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration

Start date: 2022-01-01
Primary completion: 2024-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.